Radiation after lung cancer surgery: a new hope for High-Risk patients?
NCT ID NCT06878274
First seen Feb 13, 2026 · Last updated May 01, 2026 · Updated 9 times
Summary
This study looks at whether giving radiation therapy after surgery and chemo-immunotherapy can help people with stage III non-small cell lung cancer who still have cancer cells remaining after treatment. About 118 adults will be randomly assigned to receive either radiation or no additional radiation. The goal is to see if radiation can delay the cancer from coming back and improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier de l'Université de Montréal
RECRUITINGMontreal, Quebec, H4C 3N4, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.